Your browser doesn't support javascript.
loading
AGuIX® from bench to bedside-Transfer of an ultrasmall theranostic gadolinium-based nanoparticle to clinical medicine.
Lux, François; Tran, Vu Long; Thomas, Eloïse; Dufort, Sandrine; Rossetti, Fabien; Martini, Matteo; Truillet, Charles; Doussineau, Tristan; Bort, Guillaume; Denat, Franck; Boschetti, Frédéric; Angelovski, Goran; Detappe, Alexandre; Crémillieux, Yannick; Mignet, Nathalie; Doan, Bich-Thuy; Larrat, Benoit; Meriaux, Sébastien; Barbier, Emmanuel; Roux, Stéphane; Fries, Peter; Müller, Andreas; Abadjian, Marie-Caline; Anderson, Carolyn; Canet-Soulas, Emmanuelle; Bouziotis, Penelope; Barberi-Heyob, Muriel; Frochot, Céline; Verry, Camille; Balosso, Jacques; Evans, Michael; Sidi-Boumedine, Jacqueline; Janier, Marc; Butterworth, Karl; McMahon, Stephen; Prise, Kevin; Aloy, Marie-Thérèse; Ardail, Dominique; Rodriguez-Lafrasse, Claire; Porcel, Erika; Lacombe, Sandrine; Berbeco, Ross; Allouch, Awatef; Perfettini, Jean-Luc; Chargari, Cyrus; Deutsch, Eric; Le Duc, Géraldine; Tillement, Olivier.
Afiliação
  • Lux F; NH TherAguix SAS, Villeurbanne, France.
  • Tran VL; Univ Lyon Université Claude Bernard Lyon 1, CNRS, Institut Lumière Matière, LYON, France.
  • Thomas E; Univ Lyon Université Claude Bernard Lyon 1, CNRS, Institut Lumière Matière, LYON, France.
  • Dufort S; Nano-H SAS, Saint-Quentin-Fallavier, France.
  • Rossetti F; Univ Lyon Université Claude Bernard Lyon 1, CNRS, Institut Lumière Matière, LYON, France.
  • Martini M; NH TherAguix SAS, Villeurbanne, France.
  • Truillet C; Univ Lyon Université Claude Bernard Lyon 1, CNRS, Institut Lumière Matière, LYON, France.
  • Doussineau T; Univ Lyon Université Claude Bernard Lyon 1, CNRS, Institut Lumière Matière, LYON, France.
  • Bort G; Imagerie Moléculaire In Vivo, Inserm, CEA, CNRS, Univ Paris Sud, Université Paris Saclay - Service Hospitalier Frédéric Joliot, Orsay, France.
  • Denat F; NH TherAguix SAS, Villeurbanne, France.
  • Boschetti F; Univ Lyon Université Claude Bernard Lyon 1, CNRS, Institut Lumière Matière, LYON, France.
  • Angelovski G; Institut de Chimie Moléculaire, Université de Bourgogne, Dijon, France.
  • Detappe A; CheMatech, Faculté des Sciences Mirande, Dijon, France.
  • Crémillieux Y; MR Neuroimaging Agents, Max Planck Institute for Biological Cybernetics, Tuebingen, Germany.
  • Mignet N; Dana-Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts, MA, USA.
  • Doan BT; Centre de Résonance Magnétique des Systèmes Biologiques, CNRS UMR, Université Bordeaux, Bordeaux, France.
  • Larrat B; Chimie ParisTech, PSL Research University, Unité de Technologies Chimiques et Biologiques pour la Santé (UTCBS), Paris, France.
  • Meriaux S; CNRS, UTCBS UMR , Paris, France.
  • Barbier E; Université Paris Descartes Sorbonne-Paris-Cité, Paris, France.
  • Roux S; INSERM, UTCBS U 1022, Paris, France.
  • Fries P; Chimie ParisTech, PSL Research University, Unité de Technologies Chimiques et Biologiques pour la Santé (UTCBS), Paris, France.
  • Müller A; CNRS, UTCBS UMR , Paris, France.
  • Abadjian MC; Université Paris Descartes Sorbonne-Paris-Cité, Paris, France.
  • Anderson C; INSERM, UTCBS U 1022, Paris, France.
  • Canet-Soulas E; NeuroSpin, CEA Saclay, Gif-sur-Yvette, France.
  • Bouziotis P; Université Paris-Saclay, Orsay, France.
  • Barberi-Heyob M; NeuroSpin, CEA Saclay, Gif-sur-Yvette, France.
  • Frochot C; Université Paris-Saclay, Orsay, France.
  • Verry C; INSERM, Univ. Grenoble Alpes, Grenoble Institut des Neurosciences , Grenoble, France.
  • Balosso J; Institut UTINAM, UMR CNRS 6213-Université de Bourgogne Franche-Comté, Besançon, France.
  • Evans M; Clinic of Diagnostic and Interventional Radiology, Saarland University Medical Center, Homburg/Saar, Germany.
  • Sidi-Boumedine J; Clinic of Diagnostic and Interventional Radiology, Saarland University Medical Center, Homburg/Saar, Germany.
  • Janier M; Department of Medicine, University of Pittsburgh, Pittsburgh, Pennsylvania, USA.
  • Butterworth K; Department of Radiology, University of Pittsburgh, Pittsburgh, Pennsylvania, USA.
  • McMahon S; Department of Medicine, University of Pittsburgh, Pittsburgh, Pennsylvania, USA.
  • Prise K; Department of Radiology, University of Pittsburgh, Pittsburgh, Pennsylvania, USA.
  • Aloy MT; Univ Lyon, CarMeN Laboratory Institut National de la Santé et de la Recherche Médicale U1060,INRA U1397, Université Lyon 1, INSA Lyon, Oullins, France.
  • Ardail D; Institute of Nuclear & Radiological Sciences & Technology, Energy & Safety, National Center forScientific Research "Demokritos", Aghia Paraskevi, Athens, Greece.
  • Rodriguez-Lafrasse C; Université de Lorraine, CNRS, CRAN, Nancy, France.
  • Porcel E; Laboratoire Réactions et Génie des Procédés, UMR, Université de Lorraine-CNRS, Nancy, France.
  • Lacombe S; Radiotherapy department, CHU de Grenoble, Grenoble cedex 9, France.
  • Berbeco R; Radiotherapy department, CHU de Grenoble, Grenoble cedex 9, France.
  • Allouch A; Department of Radiology and Biomedical Imaging, University of California, San Francisco, San Francisco, USA.
  • Perfettini JL; UNIV Lyon - Université Claude Bernard Lyon 1, Villeurbanne, France.
  • Chargari C; UNIV Lyon - Université Claude Bernard Lyon 1, Villeurbanne, France.
  • Deutsch E; Hospices Civils de Lyon, plateforme Imthernat, Hôpital Edouard Herriot, Lyon, France.
  • Le Duc G; Centre for Cancer Research and Cell Biology Queen's University Belfast,, Belfast BT9 7AE, UK.
  • Tillement O; Centre for Cancer Research and Cell Biology Queen's University Belfast,, Belfast BT9 7AE, UK.
Br J Radiol ; 92(1093): 20180365, 2019 Jan.
Article em En | MEDLINE | ID: mdl-30226413
Assuntos
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Radiossensibilizantes / Nanopartículas / Nanomedicina Teranóstica / Gadolínio Tipo de estudo: Diagnostic_studies / Prognostic_studies Limite: Animals / Humans Idioma: En Revista: Br J Radiol Ano de publicação: 2019 Tipo de documento: Article País de afiliação: França País de publicação: Reino Unido
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Radiossensibilizantes / Nanopartículas / Nanomedicina Teranóstica / Gadolínio Tipo de estudo: Diagnostic_studies / Prognostic_studies Limite: Animals / Humans Idioma: En Revista: Br J Radiol Ano de publicação: 2019 Tipo de documento: Article País de afiliação: França País de publicação: Reino Unido